Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check6 days agoChange DetectedAdded a Locations section with Missouri as a study site; removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe revisions metadata now shows v3.3.2 instead of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding/operating status disclaimer was removed from the page.SummaryDifference0.3%

- Check55 days agoChange DetectedThe updates are administrative edits to the trial record, including the last update date, with no changes to core study information (design, endpoints, eligibility, or treatments). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedMajor update includes a government operating status notice and a new version tag (v3.2.0); removal of a specific resource (Carcinoma of esophagus) from genetic resources.SummaryDifference3%

- Check91 days agoChange DetectedUpgrade to revision v3.1.0 with added contact details (phone and email) corresponding to support or inquiry, replacing the previous v3.0.2.SummaryDifference0.1%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.